Related Experiment Videos
[Lipoprotein anomalies in HIV infections]
A Keréveur1, M Cambillau, M Kazatchkine
1Laboratoire de Biochimie, Hôpital Broussais, Paris.
Annales De Medecine Interne
|January 1, 1996
Summary
Lipid profile changes, including low cholesterol and high triglycerides, can indicate human immunodeficiency virus (HIV) progression. These lipid alterations may be linked to disease severity and treatment effectiveness.
Area of Science:
- Biochemistry
- Immunology
- Virology
Context:
- Lipid metabolism alterations are common in acute infections.
- Variations in lipid parameters may serve as biomarkers for human immunodeficiency virus (HIV) infection progression.
- Specific lipid changes, such as hypocholesterolemia and hypertriglyceridemia, are associated with different stages of HIV infection.
Purpose:
- To explore the relationship between lipid parameter variations and HIV infection.
- To investigate the potential role of cytokines in HIV-associated dyslipidemia.
- To examine the implications of lipid changes in HIV pathogenesis, including cachexia and dementia.
Summary:
- Hypocholesterolemia is noted in asymptomatic HIV-positive individuals, progressing to hypertriglyceridemia in patients with acquired immunodeficiency syndrome (AIDS).
- Cytokine-mediated effects on lipid metabolism enzymes are hypothesized as a cause of dyslipidemia.
- Altered cholesterol metabolism may contribute to dementia, while hypertriglyceridemia could be implicated in cachexia.
Impact:
- Suggests the utility of monitoring lipid parameters in HIV-positive individuals, particularly during antiviral therapy.
- Highlights the complex interplay between viral infection, immune response, and metabolic disturbances.
- Provides insights into potential therapeutic targets for managing HIV-related complications.